YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
| Image |  |
|---|---|
| Description | scientific article published on 31 May 2016 |
| Author/s | |
| Publication date | May 31, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |